Healthcare Value Capital, LLC Buys Antares Pharma Inc, Sells Novelion Therapeutics Inc

Woodcliff Lake, NJ, based Investment company Healthcare Value Capital, LLC buys Antares Pharma Inc, sells Novelion Therapeutics Inc during the 3-months ended 2018-09-30, according to the most recent filings of the investment company, Healthcare Value Capital, LLC. As of 2018-09-30, Healthcare Value Capital, LLC owns 12 stocks with a total value of $41 million. These are the details of the buys and sells.

For the details of Healthcare Value Capital, LLC's stock buys and sells, go to http://www.gurufocus.com/StockBuy.php?GuruName=Healthcare+Value+Capital%2C+LLC

These are the top 5 holdings of Healthcare Value Capital, LLC
  1. Gilead Sciences Inc (GILD) - 100,000 shares, 18.67% of the total portfolio.
  2. Amarin Corp PLC (AMRN) - 450,000 shares, 17.71% of the total portfolio. Shares reduced by 10%
  3. Tyme Technologies Inc (TYME) - 2,175,000 shares, 14.62% of the total portfolio. Shares added by 4.82%
  4. GlaxoSmithKline PLC (GSK) - 100,000 shares, 9.71% of the total portfolio.
  5. Allergan PLC (AGN) - 20,000 shares, 9.21% of the total portfolio.
Added: Antares Pharma Inc (ATRS)

Healthcare Value Capital, LLC added to a holding in Antares Pharma Inc by 150.00%. The purchase prices were between $2.56 and $3.67, with an estimated average price of $3.09. The stock is now traded at around $3.32. The impact to a portfolio due to this purchase was 1.22%. The holding were 250,000 shares as of 2018-09-30.



Here is the complete portfolio of Healthcare Value Capital, LLC. Also check out:

1. Healthcare Value Capital, LLC's Undervalued Stocks
2. Healthcare Value Capital, LLC's Top Growth Companies, and
3. Healthcare Value Capital, LLC's High Yield stocks
4. Stocks that Healthcare Value Capital, LLC keeps buying